HALO logo
halo search icon
Verici Dx Plc
Verici Dx Plc
VRCI · LON

Verici Dx Plc

GBP0.0042

0.00 (0.00%)
21/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusExtreme OversoldHALO AllHALO Consensus Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Verici Dx Plc Overview

VRCI Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About VRCI

icon

Telephone

icon

Address

Description

Verici Dx Plc operates as a developer of advanced clinical diagnostics in organ transplant. It offers the following products for clinical validation and commercialization: Clarava and Tuteva. The Clarava product is a pre-transplant prognosis for the risk of early acute rejection. The Tuteva product is a post-transplant diagnostic focused upon acute cellular rejection, including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatinine levels. The company was founded on April 22, 2020 and is headquartered in Franklin, TN.

VRCI Price Chart

Key Stats

Market Cap

GBP6.43M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0 - 0.02

Trade Value (12mth)

US$4,954.00

1 week

-5.56%

1 month

-19.05%

YTD

-41.38%

1 year

-66%

All time high

0.95

Key Fundamentals

EPS 3 yr Growth

-56.90%

EBITDA Margin

-161.60%

Operating Cashflow

-$6m

Free Cash Flow Return

-121.70%

ROIC

-123.50%

Interest Coverage

-245.30

Quick Ratio

2.20

Other Data

Shares Outstanding (Fully Diluted)

243m

HALO Sector

Healthcare

Next Company Report Date

14-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VRCI Announcements

Latest Announcements

DateAnnouncements
19 May 26
14 May 26
11 May 26
11 May 26
01 May 26

VRCI Fundamentals

Per Share Records

Historical data

Forecast data

USD2020202120222023202220232024202520262027
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.07-0.05-0.03locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.07-0.05-0.03locklocklock
Growth
%locklocklocklock-17.925.850.7locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Verici Dx Plc (VRCI:LON)?
Halo FAQ
The current share price of Verici Dx Plc (VRCI:LON) is GBP£0.00.
What is the 52-week high share price for Verici Dx Plc (VRCI:LON)?
Halo FAQ
The 52-week high share price for Verici Dx Plc (VRCI:LON) is GBP£0.02.
What is the 52-week low share price for Verici Dx Plc (VRCI:LON)?
Halo FAQ
The 52-week low share price for Verici Dx Plc (VRCI:LON) is GBP£0.00.
What is the dividend yield for Verici Dx Plc (VRCI:LON)?
Halo FAQ
Verici Dx Plc (VRCI:LON) does not pay a dividend.
What was Verici Dx Plc (VRCI:LON) last dividend payment?
Halo FAQ
Verici Dx Plc (VRCI:LON) does not pay a dividend.
What is the franking level for Verici Dx Plc (VRCI:LON)?
Halo FAQ
Verici Dx Plc (VRCI:LON) has a franking level of 0.00%.
In which sector is Verici Dx Plc (VRCI:LON) classified?
Halo FAQ
Verici Dx Plc (VRCI:LON) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.